News
Guerbet, Jubilant Draximage Inc end collaboration
17.02.2012 10:29
Guerbet and Jubilant Draximage Inc (JDI) have decided to end their partnership for the distribution of JDI’s nuclear medicine products in Europe.
This applies to Draximage Medronate, Draximage Macrosalb and Draximage Sestamibi which had been commercialized in Germany and the United Kingdom since 2010.